Genetic, Biochemical and Clinical Insights into Primary Congenital Glaucoma
Open Access
- 9 May 2013
- journal article
- review article
- Published by Jaypee Brothers Medical Publishing in Journal of Current Glaucoma Practice
- Vol. 7 (2) , 66-84
Abstract
Glaucoma is an irreversible form of optic neuropathy in which the optic nerve suffers damage in a characteristic manner with optic nerve cupping and retinal ganglion cell death. Primary congenital glaucoma (PCG) is an idiopathic irreversible childhood blinding disorder which manifests at birth or within the first year of life. PCG presents with a classical triad of symptoms (viz epiphora, photophobia and blepharospasm) though there are many additional symptoms, including large eye ball and hazy cornea. The only anatomical anomaly found in PCG is trabecular meshwork (TM) dysgenesis. PCG is an inheritable disease with established genetic etiology. It transmits through autosomal recessive mode. A number of cases are sporadic also. Mutations in many genes have been found to be causative in PCG and many are yet to be found. Mutations in cytochrome P4501B1 (CYP1B1) gene have been found to be the predominant cause of PCG. Other genes that have been implicated in PCG etiology are myocilin, Forkhead-related transcription factor C1 (FOXC1) and latent transforming growth factor beta-binding protein 2 (LTBP2). Mutations in these genes have been reported from many parts of the world. In addition to this, mitochondrial genome mutations are also thought to be involved in its pathogenesis. There appears to be some mechanism involving more than one genetic factor. In this review, we will discuss the various clinical, biochemical and genetic aspects of PCG. We emphasize that etiology of PCG does not lie in a single gene or genetic factor. Research needs to be oriented into a direction where gene-gene interactions, ocular embryology, ophthalmic metabolism and systemic oxidative status need to be studied in order to understand this disorder. We also accentuate the need for ophthalmic genetic facilities in all ophthalmology setups. How to cite this article: Faiq M, Sharma R, Dada R, Mohanty K, Saluja D, Dada T. Genetic, Biochemical and Clinical Insights into Primary Congenital Glaucoma. J Current Glau Prac 2013;7(2):66-84.Keywords
This publication has 164 references indexed in Scilit:
- Overview of Cytochrome P450 1B1 gene mutations in patients with primary congenital glaucomaExperimental Eye Research, 2011
- Mutation spectrum of the CYP1B1 gene for congenital glaucoma in the Japanese populationJapanese Journal of Ophthalmology, 2010
- Axenfeld-Rieger Syndrome Associated with Congenital Glaucoma and Cytochrome P4501B1 Gene MutationsCase Reports in Medicine, 2010
- Null Mutations in LTBP2 Cause Primary Congenital GlaucomaThe American Journal of Human Genetics, 2009
- Genetic heterogeneity and minor CYP1B1 involvement in the molecular basis of primary congenital glaucoma in GypsiesClinical Genetics, 2008
- Glaucoma GeneticsInternational Ophthalmology Clinics, 2008
- Cyp1b1 Protein in the Mouse Eye during Development: An Immunohistochemical StudyDrug Metabolism and Disposition, 2007
- Genetic dissection of myocilin glaucomaHuman Molecular Genetics, 2004
- An Integrated Transcript Map of Human Chromosome 1p35–p36Genomics, 1997
- Cellular Pharmacology and molecular Biology of the Trabecular Meshwork Inducible glucocorticoid Response Gene ProductOphthalmologica, 1997